| 前收市價 | 33.98 |
| 開市 | 33.98 |
| 買盤 | 33.03 x 100 |
| 賣出價 | 33.27 x 100 |
| 今日波幅 | 33.16 - 33.98 |
| 52 週波幅 | 13.36 - 41.31 |
| 成交量 | |
| 平均成交量 | 319,159 |
| 市值 | 1.001十億 |
| Beta 值 (5 年，每月) | -0.29 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -6.35 |
| 業績公佈日 | 2024年10月31日 - 2024年11月04日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 52.20 |
Motley FoolWhy AnaptysBio Was Such a Healthy Stock This Week
The company's immediate future looks promising, as it has a drug that should get a clinical readout within months and a deep-pocketed pharmaceutical peer as an investor.
Investor's Business DailyAnaptysBio Surges After Sanofi Takes A Stake In $100 Million Offering
AnaptysBio stock zoomed higher Wednesday after announcing a $100 million offering that includes participation from pharma giant Sanofi.
ZacksAnaptysBio, Inc. (ANAB) Reports Q2 Loss, Misses Revenue Estimates
AnaptysBio (ANAB) delivered earnings and revenue surprises of -42.50% and 57.56%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
